Cargando…

Resection of Eloquent Located Brain Tumors by Mapping Only—A Feasibility Study

Background: Patients with eloquently located cerebral lesions require surgery that usually employs mapping and monitoring techniques for the preservation of motor and language function. However, in many cases, mapping only might be sufficient, reducing the need for technical and personnel logistics....

Descripción completa

Detalles Bibliográficos
Autores principales: Staub-Bartelt, Franziska, Rapp, Marion, Sabel, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605432/
https://www.ncbi.nlm.nih.gov/pubmed/37891736
http://dx.doi.org/10.3390/brainsci13101366
_version_ 1785127072179421184
author Staub-Bartelt, Franziska
Rapp, Marion
Sabel, Michael
author_facet Staub-Bartelt, Franziska
Rapp, Marion
Sabel, Michael
author_sort Staub-Bartelt, Franziska
collection PubMed
description Background: Patients with eloquently located cerebral lesions require surgery that usually employs mapping and monitoring techniques for the preservation of motor and language function. However, in many cases, mapping only might be sufficient, reducing the need for technical and personnel logistics. Here, we report our experiences using a device that can be operated by the surgeon independently, providing mapping techniques but omitting monitoring techniques. Methods: For monopolar and bipolar cortical/subcortical stimulation, pre-set programs were available and intraoperatively used—two enabling EMG real-time tracking of eight muscles for monopolar (cortical/subcortical) mapping, and two programs for 60 Hz stimulation, one with EMG and one without. Motor mapping was performed under continuous observation of the screened EMG signal and acoustic feedback by the surgeon. For the 60 Hz stimulation, a standard bipolar stimulation probe was connected through a second port. The preoperative application of the subdermal EMG needles, as well as the intraoperative handling of the device, were performed by the surgeons independently. Postoperatively, an evaluation of the autonomous handling and feasibility of the device for the chosen test parameters was conducted. Results: From 04/19–09/21, 136 procedures in patients with eloquently located cerebral lesions were performed by using the “mapping-only” device. Mapping was performed in 82% of the monopolar cases and in 42% of the bipolar cases. Regarding the setup and sufficiency for the cortical/subcortical mapping, the device was evaluated as independently usable for motor and language mapping in 129 procedures (95%). Gross total resection was achieved, or functional limit throughout resection was reached, in 79% of the patients. 13 patients postoperatively suffered from a new neurological deficit. At the 3–6-month follow-up, three patients showed persistent deficit (2%). All of them had language disturbances. The setup time for the device was less than 7 min. Conclusions: The device was evaluated as sufficient in over 90% of cases concerning monopolar and bipolar mapping, and the setup and handling was sufficient in all patients. With the present data we show that in well-selected cases, a very simple system providing mapping only is sufficient to achieve gross total resection with the preservation of functionality.
format Online
Article
Text
id pubmed-10605432
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106054322023-10-28 Resection of Eloquent Located Brain Tumors by Mapping Only—A Feasibility Study Staub-Bartelt, Franziska Rapp, Marion Sabel, Michael Brain Sci Article Background: Patients with eloquently located cerebral lesions require surgery that usually employs mapping and monitoring techniques for the preservation of motor and language function. However, in many cases, mapping only might be sufficient, reducing the need for technical and personnel logistics. Here, we report our experiences using a device that can be operated by the surgeon independently, providing mapping techniques but omitting monitoring techniques. Methods: For monopolar and bipolar cortical/subcortical stimulation, pre-set programs were available and intraoperatively used—two enabling EMG real-time tracking of eight muscles for monopolar (cortical/subcortical) mapping, and two programs for 60 Hz stimulation, one with EMG and one without. Motor mapping was performed under continuous observation of the screened EMG signal and acoustic feedback by the surgeon. For the 60 Hz stimulation, a standard bipolar stimulation probe was connected through a second port. The preoperative application of the subdermal EMG needles, as well as the intraoperative handling of the device, were performed by the surgeons independently. Postoperatively, an evaluation of the autonomous handling and feasibility of the device for the chosen test parameters was conducted. Results: From 04/19–09/21, 136 procedures in patients with eloquently located cerebral lesions were performed by using the “mapping-only” device. Mapping was performed in 82% of the monopolar cases and in 42% of the bipolar cases. Regarding the setup and sufficiency for the cortical/subcortical mapping, the device was evaluated as independently usable for motor and language mapping in 129 procedures (95%). Gross total resection was achieved, or functional limit throughout resection was reached, in 79% of the patients. 13 patients postoperatively suffered from a new neurological deficit. At the 3–6-month follow-up, three patients showed persistent deficit (2%). All of them had language disturbances. The setup time for the device was less than 7 min. Conclusions: The device was evaluated as sufficient in over 90% of cases concerning monopolar and bipolar mapping, and the setup and handling was sufficient in all patients. With the present data we show that in well-selected cases, a very simple system providing mapping only is sufficient to achieve gross total resection with the preservation of functionality. MDPI 2023-09-25 /pmc/articles/PMC10605432/ /pubmed/37891736 http://dx.doi.org/10.3390/brainsci13101366 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Staub-Bartelt, Franziska
Rapp, Marion
Sabel, Michael
Resection of Eloquent Located Brain Tumors by Mapping Only—A Feasibility Study
title Resection of Eloquent Located Brain Tumors by Mapping Only—A Feasibility Study
title_full Resection of Eloquent Located Brain Tumors by Mapping Only—A Feasibility Study
title_fullStr Resection of Eloquent Located Brain Tumors by Mapping Only—A Feasibility Study
title_full_unstemmed Resection of Eloquent Located Brain Tumors by Mapping Only—A Feasibility Study
title_short Resection of Eloquent Located Brain Tumors by Mapping Only—A Feasibility Study
title_sort resection of eloquent located brain tumors by mapping only—a feasibility study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605432/
https://www.ncbi.nlm.nih.gov/pubmed/37891736
http://dx.doi.org/10.3390/brainsci13101366
work_keys_str_mv AT staubbarteltfranziska resectionofeloquentlocatedbraintumorsbymappingonlyafeasibilitystudy
AT rappmarion resectionofeloquentlocatedbraintumorsbymappingonlyafeasibilitystudy
AT sabelmichael resectionofeloquentlocatedbraintumorsbymappingonlyafeasibilitystudy